Evidence map›Paper›PMID 36500363›Full record

ArticleMolecules (Basel, Switzerland)2022

The Microalga

Roberto Ciarcia, Consiglia Longobardi, Gianmarco Ferrara, Serena Montagnaro, Emanuela Andretta, Francesco Pagnini, Salvatore Florio, Lucianna Maruccio, Chiara Lauritano, Sara Damiano

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Ocean's Pharmacy: Health Discoveries in Marine Algae.Molecules (Basel, Switzerland) · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Roberto CiarciaDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.ORCID 0000-0003-4121-4905
Consiglia LongobardiDepartment of Mental, Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Largo Madonna delle Grazie n.1, 80138 Naples, Italy.ORCID 0000-0002-0788-4107
Gianmarco FerraraDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.ORCID 0000-0001-5837-7976
Serena MontagnaroDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.ORCID 0000-0001-5569-8774
Emanuela AndrettaDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.ORCID 0000-0002-4402-0914
Francesco PagniniDepartment of Medicine and Surgery, Unit of Radiology, University of Parma, Via Università n. 12, 43126 Parma, Italy.
Salvatore FlorioDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.
Lucianna MaruccioDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.
Chiara LauritanoEcosustainable Marine Biotechnology Department, Stazione Zoologica Anton Dohrn, Via Acton n. 55, 80133 Naples, Italy.ORCID 0000-0003-4580-9594
Sara DamianoDepartment of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Via Delpino n.1, 80137 Naples, Italy.ORCID 0000-0001-7798-7710
Federico II University Hospital · ITStazione Zoologica Anton Dohrn · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative disease that activates multiple signaling pathways, causing cells to produce higher levels of reactive oxygen species (ROS). Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are a major generator of ROS in leukemia, and marine natural products have shown promising activities for the treatment of hematopoietic malignancies. In the present study, we investigated the effect of the marine microalga Skeletonema marinoi (S.M.), a ubiquitous diatom that forms massive blooms in the oceans, on the human leukemia cell line K562. The effects of S.M. extract on cell viability, production of ROS, nitric oxide (NO), and apoptosis were examined. In this preliminary work, S.M. was able to decrease cell viability (p < 0.05) and increase apoptosis levels (p < 0.05) in K562 cells after 48 h of treatment. In addition, the levels of NOX, NO, and malondialdehyde (MDA) were reduced in K562-treated cells (p < 0.05), whereas the levels of SOD, CAT, and GPx increased during treatment (p < 0.05). Finally, analyzing Bax and Bcl-2 expression, we found a significant increase in the proapoptotic protein Bax and a sustained decrease in the antiapoptotic protein Bcl-2 (p < 0.05) in the K562-treated cells.

Indexed as

DiatomsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveApoptosisDNA DamageHumansK562 CellsNADPH OxidasesProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesNADPH OxidasesProto-Oncogene Proteins c-bcl-2Reactive Oxygen Speciesapoptosisleukemiaoxidative stressSkeletonema marinoi

Identifiers

PMID36500363
PMCPMC9739211
OpenAlexW4310177849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.